WO2008154350A3 - Use of tight junction agonists to suppress immune responses - Google Patents
Use of tight junction agonists to suppress immune responses Download PDFInfo
- Publication number
- WO2008154350A3 WO2008154350A3 PCT/US2008/066057 US2008066057W WO2008154350A3 WO 2008154350 A3 WO2008154350 A3 WO 2008154350A3 US 2008066057 W US2008066057 W US 2008066057W WO 2008154350 A3 WO2008154350 A3 WO 2008154350A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tight junction
- immune responses
- suppress immune
- agonists
- junction agonists
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title abstract 3
- 230000028993 immune response Effects 0.000 title abstract 3
- 210000001578 tight junction Anatomy 0.000 title abstract 3
- 102000000591 Tight Junction Proteins Human genes 0.000 title abstract 2
- 108010002321 Tight Junction Proteins Proteins 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 230000008236 biological pathway Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present invention provides materials and methods to suppress an excessive or undesired immune response. In some embodiments, agonists of biological pathways responsible for opening and closing tight junctions (e.g., tight junction agonists) are used in compositions with antigens to suppress an immune response to the antigen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94297807P | 2007-06-08 | 2007-06-08 | |
US60/942,978 | 2007-06-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008154350A2 WO2008154350A2 (en) | 2008-12-18 |
WO2008154350A3 true WO2008154350A3 (en) | 2009-02-26 |
Family
ID=40130444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/066057 WO2008154350A2 (en) | 2007-06-08 | 2008-06-06 | Use of tight junction agonists to suppress immune responses |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008154350A2 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4338297A (en) * | 1980-02-19 | 1982-07-06 | Michael Jacob G | Polypeptide active pollen immunosuppressant fraction |
US20050119171A1 (en) * | 2001-08-10 | 2005-06-02 | Genset S.A. | Human cdnas and proteins and uses thereof |
US20060165722A1 (en) * | 2005-01-14 | 2006-07-27 | University Of Maryland, Baltimore | Peptides for delivery of mucosal vaccines |
US20060276399A1 (en) * | 1998-08-03 | 2006-12-07 | University Of Maryland - Baltimore | Peptide antagonists of zonulin and methods for use of the same |
US20070122423A1 (en) * | 2001-08-17 | 2007-05-31 | Glaxosmithkline Biologicals Sa | Derp1 and proderp1 allergen derivatives |
-
2008
- 2008-06-06 WO PCT/US2008/066057 patent/WO2008154350A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4338297A (en) * | 1980-02-19 | 1982-07-06 | Michael Jacob G | Polypeptide active pollen immunosuppressant fraction |
US20060276399A1 (en) * | 1998-08-03 | 2006-12-07 | University Of Maryland - Baltimore | Peptide antagonists of zonulin and methods for use of the same |
US20050119171A1 (en) * | 2001-08-10 | 2005-06-02 | Genset S.A. | Human cdnas and proteins and uses thereof |
US20070122423A1 (en) * | 2001-08-17 | 2007-05-31 | Glaxosmithkline Biologicals Sa | Derp1 and proderp1 allergen derivatives |
US20060165722A1 (en) * | 2005-01-14 | 2006-07-27 | University Of Maryland, Baltimore | Peptides for delivery of mucosal vaccines |
Also Published As
Publication number | Publication date |
---|---|
WO2008154350A2 (en) | 2008-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007100908A3 (en) | Chimeric adenoviral vectors | |
LTPA2018010I1 (en) | Human anti-IL-23 antibodies, compositions, methods, and uses | |
WO2010011944A3 (en) | Protein screeing methods | |
WO2006083936A3 (en) | Anti-ephb2 antibodies and methods using same | |
NO20083397L (en) | Anti-EphB4 antibodies and methods for their use | |
WO2007084321A3 (en) | Antibodies to ox-2/cd200 and uses thereof | |
WO2017147542A3 (en) | Optimized transglutaminase site-specific antibody conjugation | |
WO2011047087A3 (en) | Protein detection via nanoreporters | |
NO20084356L (en) | Anti TAT226 antibodies and immunoconjugates | |
PH12019501796A1 (en) | Low ph pharmaceutical composition comprising t cell engaging antibody constructs | |
CU20120095A7 (en) | PCSK9 ANTAGONISTS | |
IL204542A (en) | Monoclonal antibodies specific for the protofibril form of beta-amyloid protein, compositions, methods and uses pertaining thereto | |
WO2007133290A8 (en) | Anti-ox40l antibodies and methods using same | |
WO2006107924A3 (en) | Ehrlichia canis diva (differentiate infected from vaccinated animals) | |
BRPI0821211A2 (en) | Humanized cd34 anti-human antibody, the method of preparation and uses thereof. | |
EP4219560A3 (en) | Integrin alpha v beta 8 neutralizing antibody | |
WO2009134429A3 (en) | Methods and compositions for modulating immunological tolerance | |
NO20083593L (en) | Anti-EphrinB2 antibodies and methods for their use | |
WO2009035738A3 (en) | Use of antibody secreting cell elispot to assess antibody responses following antigen exposure | |
WO2008043000A3 (en) | Ehrlicia canis diva (differentiate infected from vaccinated animals) | |
WO2009070507A3 (en) | Anaplasma phagocytophilum (aph) antigens and antibodies specific for anaplasma | |
WO2010056889A3 (en) | Use of an antibody and a rare-earth based crystal | |
WO2010009856A3 (en) | Goodpasture antigen binding protein and its detection | |
WO2006138324A3 (en) | Treponema pallidum antigens for vaccine development and diagnostic tests | |
WO2008091643A3 (en) | Evaluating synergy of combinations comprising an antibody in immune suppressive pathways concurrent to immunotherapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08770290 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08770290 Country of ref document: EP Kind code of ref document: A2 |